IL6 and congenital rubella syndrome: In the microscopic scenario, CRS is promoted and sustained by the activation of T cells upon engagement of the CAR by CD19, with the release of proinflammatory mediators that result in macrophage activation and IL-6 production, which sustains the inflammatory process (Table 2).